In the July e-news, we announced a new partnership with a biotech
start-up, Protein Technologies to begin work a project to design a protein
replacement therapy for AKU. In this month's e-news, we announced another new partnership,
with Dr Harbottle’s lab at Imperial College London on a promising gene therapy
idea.
We are now delighted to announce that these two groups have
begun work together, sharing gene design, HGD enzyme structure and sharing gene
vectors. This is great news for us, as it means that the expertise bought by
both teams should now mean they can move even quicker into new areas for AKU
treatment.
For more information on both groups, please check the links
below, and check back on www.alkaptonuria.info for more information on all our AKU research projects.
Protein technologies - www.protein-technologies.com
Dr Harbottle’s lab at Imperial College London - www1.imperial.ac.uk/nhli/molecular/genetherapy